Vascular Disease and Injury Preclinical Research
The development of effective cardiovascular therapeutics to treat or prevent atherosclerosis and restenosis relies on preclinical research using animal models. In Vascular Disease and Injury: Preclinical Studies, a panel of expert clinical researchers off
- PDF / 10,116,463 Bytes
- 349 Pages / 431 x 649 pts Page_size
- 116 Downloads / 236 Views
CONTEMPOR ARY CARDIOLOGY CHRISTOPHER P. CANNON SERIES EDITOR
Vascular Disease and Injury: Preclinical Research, edited by Daniel I. Simon and Campbell Rogers, 2001 Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, edited by William B. White, 2001 Preventive Cardiology: Strategies for the Prevention and Treatment of Coronary Artery Disease, edited by JoAnne Micale Foody, 2001 Nitric Oxide and the Cardiovascular System, edited by Joseph Loscalzo and Joseph A. Vita, 2000 Management of Acute Coronary Syndromes, edited by Christopher P. Cannon, 1999 Minimally Invasive Cardiac Surgery, edited by Mehmet C. Oz and Daniel J. Goldstein, 1999 Annotated Atlas of Electrocardiography: A Guide to Confident Interpretation, edited by Thomas M. Blake, 1999 Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, edited by A. Michael Lincoff and Eric J. Topol, 1999
VASCULAR DISEASE AND INJURY PRECLINICAL RESEARCH Edited by
DANIEL I. SIMON, MD CAMPBELL ROGERS, MD Brigham and Women's Hospital Boston, MA
Foreword by
VICTOR J. DZAU, MD Brigham and Women's Hospital Boston, MA
SPRINGER SCIENCE+BUSINESS MEDIA, LLC
© 2001 Springer Science+Business Media New York Originally published by Humana Press Inc in 2001 Softcover reprint of the hardcover 1st edition 2001
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication.
This publication is printed on acid-free paper. ∞ ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed
Data Loading...
